Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease

被引:2
作者
Knudtzon, Stephanie Lindgard [1 ,2 ]
Nordengen, Kaja [3 ,4 ]
Grontvedt, Goril Rolfseng [5 ,6 ]
Jarholm, Jonas [3 ,4 ]
Eliassen, Ingvild Vollo [3 ,7 ]
Selnes, Per [3 ]
Palhaugen, Lene [3 ,4 ]
Espenes, Jacob [1 ,2 ]
Gisladottir, Berglind [3 ,8 ,9 ]
Waterloo, Knut [1 ,2 ]
Fladby, Tormod [3 ,4 ]
Kirsebom, Bjorn-Eivind [1 ,2 ]
机构
[1] Univ Hosp North Norway, Dept Neurol, N-9038 Tromso, Norway
[2] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Psychol, Tromso, Norway
[3] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway
[4] Univ Oslo, Inst Clin Med, Oslo, Norway
[5] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway
[6] Univ Hosp Trondheim, Dept Neurol & Clin Neurophysiol, Trondheim, Norway
[7] Univ Oslo, Dept Psychol, Oslo, Norway
[8] Akershus Univ Hosp, Med Div, Clin Mol Biol EpiGen, Oslo, Norway
[9] Univ Oslo, Oslo, Norway
关键词
Alzheimer's disease; aging; neurofilament light chain; normative reference data; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID TAU; BIOMARKERS; DEMENTIA; PROGRESSION; PATHOLOGY; PROTEINS; MARKERS; PREDICT; IMPACT;
D O I
10.1016/j.neurobiolaging.2024.05.016
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cerebrospinal fluid total -tau (t -tau) and neurofilament light chain (NfL) are biomarkers of neurodegeneration and are increased in Alzheimer's disease (AD). In order to adjust for age -related increases in t -tau and NfL, crosssectional age -adjusted norms were developed based on amyloid negative cognitively normal (CN) adults aged 41-78 years (CN, n = 137). The age -adjusted norms for t -tau and NfL did not improve receiver operating curve based diagnostic accuracies in individuals with mild cognitive impairment (MCI) due to AD (AD -MCI, n = 144). Furthermore, while NfL was correlated with higher age in AD -MCI, no significant correlation was found for t -tau. The cox proportional hazard models, applied in 429 participants with baseline t -tau and NfL, showed higher hazard ratio of progression to MCI or dementia without age -adjustments (HR = 3.39 for t -tau and HR = 3.17 for NfL), as compared to using our norms (HR = 2.29 for t -tau and HR = 1.89 for NfL). Our results indicate that utilizing normative reference data could obscure significant age -related increases in these markers associated with neurodegeneration and AD leading to a potential loss of overall diagnostic accuracy.
引用
收藏
页码:74 / 84
页数:11
相关论文
共 72 条
[1]   The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
Albert, Marilyn S. ;
DeKosky, Steven T. ;
Dickson, Dennis ;
Dubois, Bruno ;
Feldman, Howard H. ;
Fox, Nick C. ;
Gamst, Anthony ;
Holtzman, David M. ;
Jagust, William J. ;
Petersen, Ronald C. ;
Snyder, Peter J. ;
Carrillo, Maria C. ;
Thies, Bill ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :270-279
[2]   Characterizing cognitive aging in humans with links to animal models [J].
Alexander, Gene E. ;
Ryan, Lee ;
Bowers, Dawn ;
Foster, Thomas C. ;
Bizon, Jennifer L. ;
Geldmacher, David S. ;
Glisky, Elizabeth L. .
FRONTIERS IN AGING NEUROSCIENCE, 2012, 4
[3]   Blood neurofilament light: a critical review of its application to neurologic disease [J].
Barro, Christian ;
Chitnis, Tanuja ;
Weiner, Howard L. .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (12) :2508-2523
[4]   Practice effects in healthy adults: A longitudinal study on frequent repetitive cognitive testing [J].
Bartels, Claudia ;
Wegrzyn, Martin ;
Wiedl, Anne ;
Ackermann, Verena ;
Ehrenreich, Hannelore .
BMC NEUROSCIENCE, 2010, 11
[5]   Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS [J].
Bergman, Joakim ;
Dring, Ann ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Norgren, Niklas ;
Gilthorpe, Jonathan ;
Bergenheim, Tommy ;
Svenningsson, Anders .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (05)
[6]   Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance [J].
Binette, Alexa Pichet ;
Janelidze, Shorena ;
Cullen, Nicholas ;
Dage, Jeffrey L. ;
Bateman, Randall J. ;
Zetterberg, Henrik ;
Blennow, Kaj ;
Stomrud, Erik ;
Mattsson-Carlgren, Niklas ;
Hansson, Oskar .
ALZHEIMERS & DEMENTIA, 2023, 19 (04) :1403-1414
[7]   CSF markers for incipient Alzheimer's disease [J].
Blennow, K ;
Hampel, H .
LANCET NEUROLOGY, 2003, 2 (10) :605-613
[8]   Rapid Progression from Mild Cognitive Impairment to Alzheimer's Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype [J].
Blom, Elin S. ;
Giedraitis, Vilmantas ;
Zetterberg, Henrik ;
Fukumoto, Hiroaki ;
Blennow, Kaj ;
Hyman, Bradley T. ;
Irizarry, Michael C. ;
Wahlund, Lars-Olof ;
Lannfelt, Lars ;
Ingelsson, Martin .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (05) :458-464
[9]   The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment [J].
Borland, Emma ;
Stomrud, Erik ;
van Westen, Danielle ;
Hansson, Oskar ;
Palmqvist, Sebastian .
ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
[10]   The Cellular Phase of Alzheimer's Disease [J].
De Strooper, Bart ;
Karran, Eric .
CELL, 2016, 164 (04) :603-615